Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
9-Jul-2025
INOVIQ Investor Briefing
18-Jun-2025
New treatment kills 88% of Breast and Lung Cancer cells
2-Jun-2025
Early Ovarian Cancer Screening Breakthrough
28-May-2025
Response to ASX Price Query
30-Apr-2025
Quarterly Business Update and Appendix 4C - March 2025
1-Apr-2025
Publication of NeuCA15-3 assay data
31-Mar-2025
IIQ to work with Peter Mac to validate car-exosome therapy
19-Mar-2025
Investor Webinar Presentation
17-Mar-2025
INOVIQ appoints Chief Commercial Officer
21-Feb-2025
Appendix 4D and FY25 Half Year Financial Report
1
2
Next
